Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 2/11/11 → 2/11/11 |
Funding
- PPD Development Inc
A Randomized, Multicenter, Open-Label, Phase III Study of Gemcitabine-Cisplatin Chemotherapy plus Necitumumab (IMB-11F8) Versus Gemcitabine-Cisplatin Chemotherapy Alone in the First Line Treatment of Patients with Stage IV Squamous Non-Small Cell Lung
- Mullett, Timothy (PI)